American Psychiatric Association (1994) Diagnostic and Statistical Manual for Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Arrindell, W. & Ettema, J. (2003) Symptom Checklist. Manual of a Psychopathological Indicator. Enschede: Ipskamp.
Black, D. W., Wesner, R., Bowers, W., et al (1993) A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry, 50, 44–50.
Brouwer, W. B., Koopmanschap, M. A. & Rutten, F. F. (1997) Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Economics, 6, 253–259.
Churchill, R., Hunot, V., Corney, R., et al (2001) A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technology Assessment, 5, 1–173.
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale. NJ: Lawrence Erlbaum.
College for Health Insurance (CVZ) (2002) Pharmaceutical Compass. Amstelveen: College for Health Insurance (CVZ).
Dam, Q. D., Spijker, A., Arends, L. R., et al (1998) Cost-effectiveness of psychotherapy: a feasibility study (in Dutch). Journal of Psychotherapy, 24, 5–22.
Derogatis, L. R. (1977) SCL–90: Administrative, Scoring and Procedures Manual (Revised). Baltimore, MD: Clinical Psychometrics Research Institute, Johns Hopkins University School of Medicine.
Dorrepaal, E., van Nieuwenhuizen, Ch., Schene, A., et al (1998) The effectiveness of cognitive and interpersonal therapy in depressed patients: a meta-analysis (in Dutch). Tijdschrif voor Psychiatrie, 40, 27–39.
Essink-Bot, M. L., Stouthard, M. E. & Bonsel, G. J. (1993) Generalizability of valuations on health states collected with the EuroQol questionnaire. Health Economics, 2, 237–246.
Fenwick, E., Claxton, K. & Sculpher, M. (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics, 10, 779–787.
Gloaguen, V., Cottraux, J., Cucherat, M., et al (1998) A meta-analysis of the effects of cognitive therapy in depressed patients. Journal of Affective Disorders, 49, 59–72.
Hakkaart-van Roijen, L. (2002) Manual Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness (in Dutch). Rotterdam: Institute for Medical Technology Assessment.
Jarrett, R. B. & Rush, A. J. (1994) Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry, 57, 115–132.
Karlsson, G. & Johannesson, M. (1996) The decision rules of cost-effectiveness analysis. Pharmacoeconomics, 9, 113–120.
Koopmanschap, M. A. & Rutten, F. F. (1996) A practical guide for calculating indirect costs of disease. Pharmacoeconomics, 10, 460–466.
Koopmanschap, M. A., Rutten, F. F. H., van Ineveld, B. M., et al (1995) The friction cost method for measuring indirect costs of disease. Journal of Health Economics, 14, 171–189.
Lambert, M. & Ogles, B. (2004) The efficacy and effectiveness of psychotherapy. In Berin and Garfields' Handbook of Psychotherapy and Behaviour Change (ed. Lambert, M.). New York: John Wiley & Sons.
Lavori, P., Dawson, R. & Shera, D. (1995) A multiple imputation strategy for clinical trials with truncation of patient data. Statistics in Medicine, 14, 1913–1925.
Matthews, J. N., Altman, D. G., Campbell, M. J., et al (1990) Analysis of serial measurements in medical research. BMJ, 300, 230–235.
Meltzer, D. & Johannesson, M. (1999) Inconsistencies in the ‘societal perspective’ on costs of the Panel on Cost-Effectiveness in Health and Medicine. Medical Decision Making, 19, 371–377.
Oostenbrink, J. B. & AI, M. J. (2005) The analysis of incomplete cost data due to dropout. Health Economics, 14, 763–776.
Oostenbrink, J. B., Koopmanschap, M. A. & Rutten, F. F. H. (2000) Manual for Research on Costs (in Dutch). Amstelveen: College for Health Insurance (CVZ).
Oostenbrink, J. B., AI, M. J. & Rutten-van Molken, M. P. (2003) Methods to analyse cost data of patients who withdraw in a clinical trial setting. Pharmacoeconomics, 21, 1103–1112.
Pyne, J. M., Smith, J., Fortney, J., et al (2003) Cost-effectiveness of a primary care intervention for depressed females. Journal of Affective Disorders, 74, 23–32.
Rubin, D. B. (1987) Multiple Imputation for Nonresponse in Surveys (1st edn). New York: John Wiley & Sons.
Rubin, D. B. (1996) Multiple imputation after 18+ years. Journal of the American Statistical Association, 91, 473–489.
Rubin, D. B. & Schenker, N. (1991) Multiple imputation in healthcare databases: an overview and some applications. Statistics in Medicine, 10, 595–598.
Schafer, J. (1997) Analysis of Incomplete Multivariate Data (1st edn). London: Chapman & Hall.
Sendi, P. & Brouwer, W. (2005) Is silence golden? A test of the incorporation of the effects of ill health on income and leisure in health state valuations. Health Economics, 14, 643–647.
van den Brink, M., van den Hout, W. B., Stiggelbout, A. M., et al (2004) Cost measurement in economic evaluations of health care: whom to ask?
Medical Care, 42, 740–746.
van der Sande, R., van Hoof, F. & Hutschemaekers, G. (1992) Demand and Supply in the MHC. Utrecht: NcGv.
van Hout, B. A., AI, M. J., Gordon, G. S., et al (1994) Costs, effects and c/e ratios alongside a clinical trial. Health Economics, 3, 309–319.
van Roijen, L., Essink-Bot, M. L., Koopmanschap, M. A., et al (1996) Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. International Journal of Technology Assessment in Health Care, 12, 405–415.
Wittchen, H. U. (1994) Reliability and validity studies of the WHO–Composite International Diagnostic Interview (CIDI): a critical review. Journal of Psychiatric Research, 28, 57–84.